Intersting thoughts

Search

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
AVDL. 7.80 in after-hours.. A company I've traded unsuccessfully before...but I still them follow loosely.
I've been thinking about the reason they are selling off legacy parts of the company ..profitable units...Last unit sale was July 1st for 42 MILL
A buy out is coming soon IMO . Bio is risky for sure but M@A is about to explode in Bio.
https://seekingalpha.com/news/35877...tal-sterile-injectable-drug-portfolio-for-42m

I've been following a bit of a trail from AVDL to JAZZ (ticker JAZZ) $105.00. AVDL has what JAZZ needs badly.
The existence of JAZZ almost depends on AVDL's narcolepsy drug FT218.
JAZZ isn't afraid to step in mid 3rd phase and pay up/they've done 3rd phase buyouts twice ... AVDL's FT218 is in the 3rd phase and pending approval.

Two ways to play this..I'm try to decide witch one works best..
Buy JAZZ..who's been crushed because 70% of their profits are tied to the soon to be second best narcolepsy drug on the market but minimize getting smoked on a failed trial.Less risk but I'm not interested in getting in to a long hold on JAZZ...
Or Buy AVDL and potentially double your money but open yourself up to a possible crushing with a trial failure.

Lots or rumors tying to two together out there.

Or just blow it off/I've had a couple of horrible experiences with this sort of play before and a couple of homers too.

High risk either way but "interesting"

Should have bought JAZZ todays high 151.00..
Still the same situation here between JAZZ and AVDL...JAZZ is dead without the new formulation AVDL holds.
This is just a super cheap stock to hold till the FDA rules But It wouldn't be out of character for the JAZZ board to move on AVDL sooner than later.
 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
Good read...


Long Ideas

Alibaba: When One Door Closes, Another One Opens

Dec. 7, 2020 11:53 AM ET|
About: Alibaba Group Holding Limited (BABA), CQQQ, FXI, KWEB, MCHI, Includes: BABAF, JD, MEIT, MPNGF, MPNGY, PDD, SE, TCEHY, TCOM, TCTZF
ALT Perspective

Long/Short Equity, Growth At Reasonable Price, Contrarian, Deep Value


(10,557followers)




Summary
All three major US stock indices finished at fresh records while Chinese indices underperformed.
Despite estimates-beating PMIs, actions from both the U.S. and Chinese government led to soured sentiment.
JD Digits' involvement in China's digital yuan trial bodes well for Alipay's prospects.
Alibaba continues to have positive news flow in the electric vehicle/autonomous driving space.
The ho-hum nature of the ground-breaking digital banking award in Singapore to Ant Group exemplifies how investors are shunning Alibaba due to past scars.



By ALT Perspective for Chinese Internet Weekly
On Friday, all three major US stock indices finished at fresh records, capping a buoyant week. Investors looked past the rising coronavirus cases, choosing to stay positive on the vaccine developments and indications that new US stimulus could be forthcoming.
There was also good news from China in the form of November's purchasing managers indices [PMIs] exceeding forecasts. However, these were overshadowed by the House's passing of the Holding Foreign Companies Accountable Act and an expansion of a blacklist of alleged companies linked to the Chinese military.
In the past week, the representative ETFs of Chinese companies (CQQQ)(FXI)(MCHI) were in the red, declining 1.6 percent to 2.9 percent. On the contrary, their U.S. counterparts (QQQ)(DIA)(SPY) rallied 1.1 percent to 2.2 percent to set new highs.
saupload_89f5f6cc0bddd639f40f0e5e9fd89762.png
Data by YChartsReaders of my recent articles covering U.S.-listed Chinese companies often lament the lack of mention of the implications of the "delisting" Act. As I have already done so at length in several prior updates, and there are numerous valuable inputs from astute readers in the comments section of those pieces, I encourage interested readers to head there instead.

At the risk of not doing the great comments from readers on the subject justice, here are the key ideas:

  • Many vested interests in the U.S. could lobby for the listings to remain,
  • The majority of the U.S.-listed Chinese companies employs the Chinese entities of the Big Four auditors, which gives them confidence that high standards have already been complied with,
  • If push comes to shove, fund managers, such as those running exchange-traded funds, would be happy to take over affected shares from retail investors,
  • Given that it would take three failures over the same number of years for a forced delisting to happen, the company would have plenty of time to arrange a secondary listing elsewhere and make the new shares fungible with its U.S. ones.
There are also mitigating developments. The Chinese authorities have expressed their willingness to seek a resolution to the complaints. The Securities and Exchange Commission [SEC] has also proposed a "co-audit solution" based on the President's Working Group [PWG] recommendations to allow the Big Four accounting firms to validate their Mainland subsidiaries' audit work.
As I was writing, I received the weekend newsletter from Bloomberg where the headlines provided a succinct sum-up on the topic:
44555366-16071757599248598.png

Source: Google (screenshot)
There were also a couple of self-inflicted bruises. In late October, proposed changes in Chinese regulations forced a suspension at the 11th hour of the intensely anticipated initial public offering of Alibaba's (BABA) Ant Group. Following the issuance of draft proposals for new rules to root out monopolies in the internet sector by China's financial regulator on November 10, the authorities declared plans to impose "special and innovative regulatory measures" on the country's financial technology giants.

Guo Shuqing, chairman of the China Banking and Insurance Regulatory Commission and Party Secretary of the central bank, emphasized that the proposed regulations "should cover all financial institutions, businesses and products," implying that the moves were not targeted at any company. Perhaps he didn't want anyone to think the government was being petty, acting in the response of what Jack Ma, founder of Alibaba Group, said in an offensive speech in October.
Guo also threw another curveball on investors, calling China's property market the biggest "gray rhino" in terms of financial risks. He cited loans related to the property market currently accounting for 39 percent of total bank loans in China. Already a substantial share, there's also a large amount of bonds, equities, and trust investments with exposure to it to contend with.
Interestingly, some optimists told me they were expecting a diversion of funds from a potential curtailment of property investments (or speculations, if you prefer) to pour into the Chinese equities markets. Hence, the news should be regarded as a positive one for the stock market. Apparently, the dour performance of the Chinese stock indices suggests this view is in the minority.
Some readers were concerned that the recent signals sent by the Chinese government seemed to indicate it is becoming more controlling and possibly overreaching to the extent of stifling the business growth. On the contrary, I believe the heightened scrutiny facilitates the ongoing reforms to push to a free market.
The "opening up" could make it more likely that investors will pile into a small number of highly profitable companies and those deemed to have better prospects. Such clustering could concentrate funding to the market favorites and result in them becoming too dominant and powerful. Tesla (TSLA), and the Chinese electric vehicle manufacturers, is arguably a good example of this phenomenon.
Going back to the PMIs. Both the official and privately compiled readings surpassed consensus forecasts for another month. It seemed the economists were addicted to being pessimistic about China's economy, choosing to believe that each month's survey results were too good to be sustainable.

From the estimates, we could see that economists were expecting a slowdown from October, essentially the same pattern that was observed from the previous months. The actual results proved them wrong again, delivering not just a simple beat, but a substantial one and bettering October's scores.
The official manufacturing PMI for November came in at 52.1, higher than October's 51.4 and beating the consensus estimate for 51.5. The official non-manufacturing PMI was clearly in the expansionary territory at 56.4, higher than October's 56.2 and the consensus estimate for 56.0.
The Caixin China General Manufacturing PMI compiled by IHS Markit (INFO) for November was 54.9, beating the consensus at 53.5 handily and was higher than October's reading of 53.6. The indicator reflected the sharpest improvement in conditions since November 2010, a decade ago! Critically, both the output and new orders indices increased at the fastest rates in ten years while employment expanded at the quickest pace since May 2011.

Sources: Caixin, IHS Markit
The Caixin China General Services PMI similarly posted a solid beat at 57.8 versus the consensus estimate for 56.4 which implied the economists were anticipating a slowdown from October's 56.8. The services employment index chart looks even better than the manufacturing one, with the gauge staying in positive territory for the fourth consecutive month and achieving the highest reading since October 2010.
Sources: Caixin, IHS Markit

To put the magnitude of the optimism in perspective, Dr. Wang Zhe, Senior Economist at Caixin Insight Group, remarked:
"The gauge for business expectations reached the highest point since April 2011. A majority of surveyed service providers were confident about the control of the epidemic and the economic recovery, while only 2% said they were pessimistic."
The Chinese Internet sector representative ETF, the KraneShares CSI China Internet ETF (KWEB), was similarly dragged down by the negative sentiment, closing down 2.8 percent for the week. Among the key holdings of the KWEB ETF, the share prices of e-commerce players Bilibili (BILI), and Pinduoduo (PDD), together with Baidu (BIDU) and Trip.com (TCOM), ended the week with positive gains.
At the other end of the spectrum, Meituan-Dianping (MEIT)(OTCPK:MPNGF)(OTCPK:MPNGY) and NetEase (NTES) posted hefty losses, declining 8.6 percent and 6.4 percent respectively. Meituan-Dianping reported Monday a 28.8 percent revenue growth year-on-year for the third quarter this year, beating consensus estimates.
However, investors were worried about the impact of the looming regulatory threat from Beijing as mentioned earlier, due to its dominance in food delivery. There were also concerns that the announced plans to expand its warehouse network and logistics capabilities so that Meituan-Dianping could fulfill its strategy of delivering "everything to customers' homes" would result in significant capital expenditures in the coming years.
Heavyweights Alibaba and JD.com (JD) were lower by 3.3 percent and 4.7 percent respectively, despite positive news flows. JD.com's healthcare unit, JD Health, is well on track for its public debut in Hong Kong on December 8. The IPO, priced at HK$70.58 (US$9.1) per share, raised $3.5 billion.
An August 17 update from JD Health

Source: JD.com
JD Health is in the hot businesses of online pharmacy and telehealth services, accelerated by the COVID-19 pandemic. Incidentally, thanks to the ill-fated Ant Group's IPO, JD Health has the honor to be Hong Kong's biggest debut of 2020. This is despite the IPO size being lower than the initial range touted to be up to $4 billion at the high end, which would have brought the valuation to nearly $30 billion.
Besides JD Health, JD.com also has another promising unit in fintech, JD Digits. I shared the history and prospects of the division in the article JD.com: Tremendous Value To Be Unlocked Soon. On Saturday, JD Digits revealed that it would accept digital yuan as payment for some products on its online mall, boding well for its public listing in the future.
The first virtual platform to accept China's central bank digital currency [CBDC], JD Digits would help test the digital yuan concept in the city of Suzhou. The country is relatively advanced in its evaluation of CBDCs in the world. In April, the trial had already been extended to foreign consumer companies like Starbuck (SBUX), McDonald's (MCD), and Subway.
The involvement of JD Digits helps dispel somewhat the concerns of the shareholders of Alibaba and Tencent (OTCPK:TCEHY)(OTCPK:TCTZF) that their mobile wallets could be rendered useless when the CBDC is fully implemented. Whether it's legal tender traditional money, CBDCs, or cryptocurrencies, digital wallets are still needed for storage and distribution.
Mobile payment apps in China (top left to right, bottom left to right): Alipay, WeChat Pay, QQ Wallet, JD Pay
44555366-15884287855932062.jpg
Source: ALT Perspective
Speaking of cryptocurrencies, we are all aware of how the share price of Square (SQ) has benefited since it announced enabling its crypto wallet feature. With ****** (PYPL) jumping onto the bandwagon, cryptocurrencies appear to be going mainstream. I am wondering about how much the valuation of Ant Group might appreciate if it was listed and Alipay announces its entry into the crypto wallets arena.


Source: Ant Group
With electric cars and autonomous driving now the rage, it's puzzling why investors were not excited by the announcement by Alibaba-backed AutoX. COO Jewel Li told CNBC's Squawk Box Asia on Friday that self-driving cars without human drivers as a back-up were now being tested in Shenzhen, the city dubbed China's Silicon Valley. The startup plans to expand to 10 cities globally in the next six months.
I mentioned in an earlier article that SAIC Motor, China's largest state-owned automobile manufacturer, established a private equity fund to finance a collaboration with Alibaba to invest in smart electric vehicle technologies. YunOS (also called Aliyun OS), developed by Alibaba Cloud, has already been deployed in some of SAIC's Roewe sports-utility vehicles enabling features such as an intelligent digital map, voice control, action cameras, and internet ID.
Alibaba's Gaode Maps (AutoNavi in English) is currently the most downloadedfree iOS navigation app in China. It recently incorporated a new AR navigation feature that warns drivers of upcoming collisions, pedestrians, and traffic lights. These developments suggest Alibaba could be a worthy contender in the hot field of electric vehicles and autonomous driving.
On Friday, the Monetary Authority of Singapore [MAS] revealed four successful digital bank applicants. The highly anticipated announcement saw an entity wholly-owned by Sea Ltd. (SE) winning the Digital Full Bank [DFB] license. The company often referred to as Southeast Asia's Tencent, saw its share price rising as much as 10 percent before paring some gains at the close on profit-taking.
An entity wholly-owned by Ant Group was awarded a license for Digital Wholesale Bank [DWB]. The MAS defined the difference between DFB and DWB as follows: "DFBs will be [sic] provide a wide range of financial services and take deposits from retail customers, while DWBs will focus on serving SMEs and other non-retail segments."

Ostensibly, Ant Group's DWB license is a diminished operation than Sea's DFB. However, the category fits very well into Alibaba's stated ambition to help millions of SMEs. It also allows the fintech unit to learn from the experience before applying for an upgrade when the opportunity arises in the future, avoiding the losses from potential mistakes.
As the saying goes, when one door closes, another one opens. The Singapore DWB license provides Ant Group with a whole new area of growth, even as the "door" in China has not closed but just partially blocked. With Alibaba owning a third of Ant Group and seeing nary an uptick is adding to the mystery of its share price's doldrums, also considering the other positive developments as mentioned earlier.
As explained in a past issue of the Chinese Internet Weekly, I found the KWEB ETF holding the most representative stocks in the sector. As such, an overview of the week's share price movements of the top few holdings of KWEB as compared with the ETF itself is provided as follows for convenient reference especially for the stocks mentioned in this article.
saupload_baeb95c0b99ea80d3dbedc53248ca02e.png
Data by YChartsWhat is your take? Share your thoughts with the Seeking Alpha community in the comments field. If you like this article, click on the orange "Follow" button and make sure the "Get email alerts" is checked so that you will be informed of my next article the moment it's published. Leaving a comment would ensure you have access to the comments stream after the article goes behind the paywall.

Disclosure: I am/we are long BABA, BIDU, JD, TCEHY, TCOM. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.




Like this article


















 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
LISTEN TO TODAY'S PODCAST AVAILABLE AT 8AM ON:
Top News
The U.K. began administering the first COVID-19 vaccines to the public this morning after becoming the first country in the world to approve a jab from Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX). The first recipient was grandmother Margaret Keenan, who turns 91 next week. She received the shot at 6:31 a.m. at University Hospital Coventry (U.K. time, 07.31 CET), one of a network of hospital hubs where the initial phase of the U.K. program will be rolled out on what has been dubbed "V-Day." The first 800,000 doses in the Britain are going to people over 80 who are either hospitalized or already have outpatient appointments scheduled, along with nursing home workers. U.S. and EU authorities are also reviewing the vaccine, alongside rival products developed by Moderna (NASDAQ:MRNA), and a collaboration between Oxford University and drugmaker AstraZeneca (NASDAQ:AZN).
Covid
Over in the U.S., hospitals are rushing to firm up plans for deciding which high-priority groups can receive the COVID-19 vaccine first, with initial supplies widely expected to fall short. December vaccine deliveries are forecast to only be enough for about 20M people, according to federal officials, slightly less than the 24M needed to vaccinate all front-line medical professionals and long-term care residents. President Trump is meanwhile expected to sign an "America First" executive order today designed to ensure that U.S. efforts to assist other countries in vaccinating their populations against COVID-19 take on a lower priority than domestic inoculations. The "Vaccine Summit" at the White House will also feature talks with administration officials and drug distributors, who will discuss the process of reviewing vaccine candidates and distributing them, just days before the FDA is expected to authorize a promising vaccine made by Pfizer (NYSE:PFE).

Q from your company Slack channel: Can your boss fire you if you refuse to get a COVID vaccine? Yes, but there are may be a few exceptions (medical reasons, if the workforce is unionized, or if taking it is against a "sincerely held" religious belief).

Roughly four in 10 Americans say they would "definitely" or "probably" not get a vaccine, according to a recent survey by Pew Research. To achieve herd immunity, experts say that about 70% of the population needs to be vaccinated or have natural antibodies.
Sponsored by Masterworks
It’s not so great in your investment portfolio. The S&P is trading over 37x earnings - that’s frothy enough to fill a stadium full of Venti cappuccinos. So how do you avoid the froth while preserving your net worth? You invest outside of the stock market into alternatives like art. Don’t just take it from us - 86% of wealth managers recommend investing in art, an asset class that has a correlation factor of 0.13.

With the Fed injecting money into the economy at a staggering rate (25% of all US Dollars to ever be in existence were created in the last 9 months), savvy investors are allocating a portion of their portfolio to hard-money assets, like art, to hedge against inflation. Masterworks is the only platform that lets you invest in blue-chip art - from artists like KAWS, Basquiat and Murakami. Just recently, Masterworks sold their first Banksy masterpiece for a 32% return - that's nearly double the S&P over the same time period. Seeking Alpha subscribers can skip the waitlist today with this special link.

(See important information).*
Stocks
What do increasing service disruptions on trading platforms like Robinhood and the pandemic market rally have in common? It's a sign of the DIY investing atmosphere. In many ways, the retail investor has become a more powerful collective force than the professional investor, and they simply don't care about the same things as the experts. In fact, individual investors now account for roughly 20% of stock-market activity on average and nearly one-quarter of tradeson peak days, according to Joe Mecane, the head of execution services at Citadel Securities (the firm is the leading retail market maker in the U.S.).

Quote from Jim Cramer: The returns of the individual investor have changed the "entire character of the market," and the professionals are no longer the only cohort that matters.

Ever since the dot-com bubble in 2001, every big market move has been framed as "what could go wrong." Conventional wisdom also said stocks could not be trusted as an asset class, and should be traded together as a unit, as they tend to lose their value quickly if things go awry. That theory only grew in popularity after the financial crisis, leading many institutional investors into ETFs or index funds (and the rest into the safety of bonds) instead of picking individual stocks. A new generation of investors, which entered the market after the rise of commission-free trading, is turning that mentality on its head. They're much more upbeat than the older generation and they're doing their own research on platforms like Seeking Alpha, instead of paying attention to the upgrades and downgrades of Wall Street analysts. The retail bros also don't care about traditional parameters of valuation (P/E and P/S ratios) and could always trade out of a stock for free because of commission-free trading.

Mentality of the retail investor: 1) Distrust of index funds (they like stock picking), 2) Rigorously independent (trades based on their own research), 3) Risk taking (buying during the height of the pandemic), 4) ESG investing (believe in environmental sustainability as a business model, not just an ethos - i.e. Tesla).
New Technology
Uber (NYSE:UBER) is swapping its self-driving car operations for a minority stake (26%) in Aurora Innovation, the driverless vehicle startup backed by Sequoia Capital and Amazon (NASDAQ:AMZN). CEO Dara Khosrowshahi, who will join the Aurora board, has already moved to restructure the ride-hailing giant to deliver on a promise to make the company profitable, scaling back many of its expensive side projects like electric bikes and flying cars.

Full details: Uber will invest $400M in the startup and transfer over about 1,200 employees from its self-driving unit, tripling the headcount of Aurora. The latter is led by autonomous-driving pioneer Chris Urmson, who helped launch Google's (GOOG, GOOGL) autonomous-driving project, and would notch a $10B valuation following the transaction with Uber (it was last valued at $7.25B in April 2019).
Media
Reports have been surfacing that CNN (NYSE:T) President Jeff Zucker will depart the network after the presidential inauguration, but he may not be the only mainstream media leader to leave the position. Phil Griffin, the president of MSNBC (NASDAQ:CMCSA) for the past twelve years, will step down shortly after Joe Biden's inauguration in January, a major shakeup at a news channel that has raised its profile with political coverage, but has struggled to keep pace with rivals.

Bottom line: While November was MSNBC's most-watched month in its 24-year history, the channel finds itself in a challenging competitive landscape at the end of President Trump's time in office. MSNBC still ranked third in cable news behind CNN and Fox News (NASDAQ:FOX) last month.

Rashida Jones has been named as Griffin's successor, launching her to one of the highest echelons in TV news and making her the first Black female executive to run a major general news cable network. "She has an outstanding track-record and she leads with a laser-like focus and grace under pressure. I know she will be an excellent leader for MSNBC," NBCUniversal News Group Chair Cesar Conde wrote in an internal memo.
What else is happening...
Federal judge shuts down TikTok ban in win for ByteDance (BDNCE).

Palantir (NYSE:PLTR) closes up 21% on report of new FDA contract.

MicroStrategy (NASDAQ:MSTR) raising $400M to buy more Bitcoin (BTC-USD).

JD Health, healthcare unit of JD.com (NASDAQ:JD), soars in Hong Kong debut.​
Monday's Key Earnings
Stitch Fix (NASDAQ:SFIX) +33.6% AH on earnings smasher, blasting past estimates.
Toll Brothers (NYSE:TOL) -2.5% AH as Q1 guidance came in soft.

Today's Markets
In Asia, Japan -0.3%. Hong Kong -0.8%. China -0.2%. India +0.3%.
In Europe, at midday, London -0.5%. Paris -0.7%. Frankfurt -0.3%.
Futures at 6:20, Dow -0.4%. S&P -0.4%. Nasdaq -0.2%. Crude -0.4% to $45.57. Gold -0.1%at $1864/90. Bitcoin -1.9% to $18851.
Ten-year Treasury Yield flat at 0.93%​
Today's Markets

 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
[h=1]Big red spot here..trading 50 times earnings.


[FONT=Verdana, Arial, Helvetica, sans-serif]Twist Bioscience: A Breakout Year For Its Synthetic DNA Platform[/FONT][/h]
Shares of Twist Bioscience are up over 520% in 2020 supported by accelerating demand for synthetic DNA and next-generation-sequencing.
Launch of several new products including expanding relationships with key biopharma customers are likely to drive growth going forward.



Twist Bioscience Corp. (TWST) has established itself as a leader in DNA synthesis with its proprietary process to automate and commercialize synthetic DNA production. While the concept is not new, Twist uses its expertise in silicon and software to miniaturize thousands of parallel chemical reactions and write strands of DNA at a lower cost with significantly more output compared to alternative methods. There is a growing range of applications for this type of "engineered biology" across various industries. The company has seen a surge in demand for next-generation sequencing "NGS" along with an expanding market for various related products. While the stock is up over 520% year to date and pricey at the current valuation, we believe Twist is well-positioned to capture growth opportunities supporting a positive long-term outlook.

(Seeking Alpha)
[h=2]TWST Fiscal 2020 Recap[/h]The company reported its fiscal Q4 earnings on November 23rd with a GAAP EPS loss of $0.54, favorably $0.14 ahead of estimates. More impressive was the quarterly revenue at $32.4 million, climbing 106% year-over-year and $9.8 million ahead of consensus expectations. Indeed, this was a massive quarter for the company that represented a breakout in growth in revenue and new orders. For the full-year, revenue reached $90.1 million, up 66% from $54.4 million in 2019 while the gross margin improved to 31.8% from 12.8%.


(Source: Company IR)
The trends here coincide with an accelerated use of gene editing techniques via "CRISPR" technologies in several markets. Essentially, Twist allows customers to order specific genes used to conduct research and development with varying applications in healthcare for the production of new therapeutics and molecular diagnostics, industrial materials science, agriculture, and even technology for potential data storage. Since this type of work is often based on trial and error, customers require many variations of genes representing recurring revenues and long-term business relationships.

(Source: Company IR)
It's important to note that while the company benefited this year with the launch of some COVID-19 related synthetic controls products used to sequence the virus, management made the distinction that the current growth story is beyond any pandemic boost. Orders for the core NGS and synthetic bio "Synbio" business highlight the underlying positive momentum. From the conference call:
I'd like to note that unlike some of our peer companies, our record revenue is not a function of COVID-19-related products. And in fact, while our synthetic RNA control for SARS-CoV-2 and our NGS panel to sequence the virus definitely contributed to our revenue, it is our stable Synbio and NGS products with growing initial revenue from our Biopharma division that has catapulted our success this fiscal year. Illustrating our momentum, we reported record orders of almost $117 million for the full-year, with $42.3 million for the fourth quarter, setting the stage for growth into 2021.
One of the attractions to the Twist platform is an online ordering process including a custom option for a back-end API for the supply chain management. The company expects to add business-to-business capabilities that would allow the platform to be integrated into existing industry-specific software systems. Management highlighted this area of focus that can support a more streamlined ordering experience for customers. From the conference call:
Currently, we have an exceptional frictionless e-commerce system that tracks orders from initial purchase to shipment. We are now focused on building capabilities to facilitate business-to-business interactions that will expedite all our placements to enable us to be an approved bundle within certain systems. For instance, currently, a customer, the University of California is required to generate a PO within their accounting system before placing an order. A B2B integration will enable these customers to place an order on our website without needing a specific PO from their institutions, removing significant barriers to order.

(Source: Company IR)
In terms of the balance sheet, the company ended the fiscal year with $290 million in cash and equivalents with only limited long-term debt reported at $1.4 million. While operating cash flow was negative $140 million for the year, the company's current ratio of nearly 10x highlights an overall solid liquidity position.
Twist has been successful in raising cash via equity offerings. Most recently, the company announced a $300 million sale of common stock to support continued growth opportunities. The company has planned a new manufacturing facility in the Bay Area of California in a project known as the "Factory of the Future" expected to be completed by 2022 that will double the current capacity including a faster turnaround time for all products.

[h=2]Management Guidance and Consensus Expectations[/h]Twist is currently guiding for fiscal 2021 revenue between $110 and $118 million which at the midpoint implies a 26.5% y/y increase from the fiscal 2020 result. An estimated net loss of around $140 million would be roughly the same as 2020 based on ongoing investment spending with budgeted CAPEX at $30 million.
For the year ahead, the company has set several operational objectives to generate new growth opportunities. In Synbio, there is an expectation to launch clonal ready gene fragments this year while ramping up pharma-focused products.
In NGS, the company sees upside in converting customers who are currently using competitor's microarray technology into Twist's platform. To this point, management highlighted a large customer making the switch in Q4 providing a roadmap for similar conversions going forward.
For data storage applications, efforts are still being directed at demonstrating a working prototype of a 300-nanometer silicon synthesis on a 1-micron pitch. In November it was announced that Twist was allying with a group that includes Microsoft Corp. (MSFT), Illumina Inc. (ILMN), and Western Digital (WDC) to collaborate on an industry roadmap for the future widespread commercial adoption.
(Source: Company IR)
According to consensus estimates, the forecast for fiscal 2021 revenue at $115 million is in line with the management guidance. The growth momentum should be maintained for the foreseeable future approaching $188 million by fiscal 2023. The market expects negative EPS of $2.65 for the full year 2021 with a narrowing loss through 2023.


(Seeking Alpha)
[h=2]Analysis and Forward-Looking Commentary[/h]In the world of biotech which is often seen as the wild-wild-west of investing recognized for high risk and high reward opportunities, it's clear that Twist Bioscience is one of the most exciting names in the market at the cutting edge of this important technology. While we're encouraged by the latest results and progress in commercializing the products, the story here is hardly a secret considering TWST is up over 60% in just the past month. With the stock trading at a forward price to sales multiple of 50x, this is an objectively expensive growth premium considering the market cap of $5.9 billion in the context of recurring losses for the foreseeable future.
That being said, it's clear the operational outlook is positive as Twist Bioscience is well-positioned to capture a real market opportunity as the applications for synthetic DNA expand long term. Investors today are betting that the addressable market will grow and Twist will build on its market share by converting new demand into long-term recurring revenues. The plan for the new facility capable of doubling capacity is a sign of management's confidence and optimism.
The risk here is that a lot can happen between now and when the economics can start to make sense 5 to 10 years down the line at the current valuation. Even as Twist's portfolio of patented processes and platform represent a market advantage, there are in fact competitors that offer alternative solutions for particular applications.
In Twist's own annual report, management highlights several companies among emerging players and major corporations that currently provide core synthetic biology products, antibody discovery solutions, NGS sample prep, and DNA digital storage and continue to innovate including Genscript Biotech Corp. (OTC:GNNSF), 'GeneArt' owned by Thermo Fisher Scientific Inc. (NYSE:TMO), Sigma-Aldrich Corp. owned by Merck KGaA (OTCPK:MKKGY), Integrated DNA Technologies Inc., a subsidiary of Danaher Corp. (DHR), Agilent Technologies Inc. (A), and the previously mentioned Illumina Inc. among others. Our point here is that this is not a monopoly and the market will be contested representing uncertainties to the long-term growth outlook.

We note that Illumina Inc. with a market cap of $52 billion is likely the closest peer as it offers gene sequencing tools and sells the "microarray" NGS scanners. While there are significant differences in each business model and product offerings, Illumina stands out as currently profitable and trades at a significantly lower price to sales multiple of 16x. In many ways, Twist is attempting to capture market share in key categories from Illumina with alternative solutions the company believes to be superior.
saupload_8e5f2f640426e1ab0da035b00a346c5d.png
Data by YChartsTo be clear, we are bullish on Twist long term and expect it to maintain its growth momentum. Our concern here is that even the ~30% revenue growth expected in each of the next three years may not be enough to justify the current level of optimism and price tag of the stock. To the upside, the company will likely need to exceed current growth estimates and show accelerating product demand for the stock to climb higher. We question how much of the positive outlook is already priced in.
Overall, we rate shares of TWST as a hold with a year ahead price target of $125 giving the company the benefit of the doubt to grow into its valuation. We expect shares to be volatile with sentiment correlated to broader trends in high-growth stocks and financial market conditions. We would take a more bullish view on the stock on any possible correction under $100 offering an improved reward-to-risk setup.
Add some conviction to your trading! We sort through +4,000 ETFs/CEFs along with +16,000 U.S. stocks/ADRs to find the best trade ideas. Click here for a two-week free trial and explore our content at the Conviction Dossier.


Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.



Like this article

















Never miss an update about TWST.





[h=2]Recommended for you:[/h]
 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
Sold Half my TWST @147.50... Taking the money here on a 11% jump today.

I've had stocks "run" but never anything like this...I've learn my lesson with this situation before.
I want this to dip more than anything now. Wow.
 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
TWST 137.00


new-jt-banner-newsletter.png

[FONT=Arial, Helvetica, sans-serif]Global Market Comments
December 8, 2020
Fiat Lux
[/FONT]
[FONT=Arial, Helvetica, sans-serif]FEATURED TRADE:[/FONT]
[FONT=Arial, Helvetica, sans-serif](THE BRAVE NEW WORLD OF ONLINE RETAILING),
(SNAP), (GPRO), (APRN), (SFIX)
[/FONT]
[FONT=Arial, Helvetica, sans-serif]
mti-pos-88.jpg
[/FONT]


The Brave New World of Online Retailing

I was flying on first class flight on Virgin America from New York to San Francisco last year, and all I can say is that you meet the most interesting people in first class.[FONT=Arial, Helvetica, sans-serif]The woman sitting next to me was dark-haired, rail-thin, elegantly dressed, and utterly gorgeous. She addressed the flight attendant in a heavy Italian accent.

I hadn’t been to the former Roman empire since the summer, so I thought I would give my Italian a workout.

What I learned was amazing and opened up nothing less than a peek into the future of retailing.

I am always on the lookout for the next “big thing” than can generate a great Trade Alert, and suddenly here was a golden opportunity

It turned out that the woman was a senior executive with the fashion house Prada, based in Milan. Why was a fashion executive flying to a city where the hoodie and torn designer jeans were the primary means of dress?

She was flying halfway around the world to develop a relationship with Stitch Fix (SFIX), the hottest new concept in online apparel retail.

The fact that major companies were flying people in from Europe to check out a small startup said a lot right there.

The company’s business model is very simple, if not brave.

Consumers fill out a personal profile that includes every conceivable measurement, preference, and lifestyle. A personal stylist is then assigned to you who mails you a monthly box of items they think you would like.

For this service, you are charged a “stylist” fee of $20, which can then be applied as a credit towards any purchases.

You simply buy the items that appeal and mail the rest back. An artificial intelligence-driven algorithm records your picks and returns and then predicts what you are most likely to buy next time.

After several of these cycles, the algorithm knows what you like better than you do and will even mail you special offerings at a discount.

Along the way, Stitch Fix will introduce you to styles and brands that you never would have thought of. In order words, it does all the thinking for you.

The company has already clocked $1 billion in revenues in 2017 and is on an exponential growth trajectory.

Stitch Fix boasts an operating gross margin of 44%, well in excess of traditional retailers like Macy’s (M), Kohl’s (KSS), The Gap (GPS), and JC Penny (JCP).

Originally targeting Millennials, it quickly learned that its real market was with middle-aged professional women who don’t have time to shop.

It is already marketing 700 brands and is working to establish its own brands where the real margins are.

Some 95% of the firm’s employees are women.

The recent history of tech IPOs has not been great ((SNAP), (GPRO), (APRN), etc.). However, given the current online retail explosion, I have great hopes for (SFIX).

Just to have some fun, I filled out a profile but listed my age as 25. I can’t wait to see what they send me.

Hopefully, I won’t blow up their algorithm.

To place your first order with Stitchfix, please visit their website by clicking here.
[/FONT]

[FONT=Arial, Helvetica, sans-serif][/FONT]
[FONT=Arial, Helvetica, sans-serif]
sfix-dec8.png
[/FONT]​
[FONT=Arial, Helvetica, sans-serif][/FONT][FONT=Arial, Helvetica, sans-serif] [/FONT]
[FONT=Arial, Helvetica, sans-serif][/FONT]
[FONT=Arial, Helvetica, sans-serif]
gpro-dec8.png
[/FONT]​
[FONT=Arial, Helvetica, sans-serif][/FONT][FONT=Arial, Helvetica, sans-serif] [/FONT]
[FONT=Arial, Helvetica, sans-serif][/FONT]
[FONT=Arial, Helvetica, sans-serif]
snap-dec8.png
[/FONT]


Quote of the Day

“A man who is the master of patience is the master of everything else,” said George Saville, a professional soccer player.
patience.png







 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
Formally great MNK is now trading as MNKKQ and is in bankruptcy but they are a company with more than decent product in the pipeline.
If you like Craps this is a buy....It'll pop both up and down here for a bit but you'll need to watch it from the moment you buy..it'll have a few 50% days both directions and there is great daily liquidity so far...I'm buying next week early but just a few thousand shares for excitement...I want it to dive here in the next few days but it might pop the other direction..You could get stuck with it for a bit but I like the odd's to make a bit of pocket money selling it on moves....Gotta be a shark with this one..beware

https://www.cnbc.com/quotes/?symbol=MNKKQ


Up 60% today and sold....It'll do this again a few times, buy in the teens and wait...I love waiting.

https://www.cnbc.com/quotes/?symbol=MNKKQ
 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
new-jt-banner-newsletter.png

[FONT=Arial, Helvetica, sans-serif]Global Market Comments
December 10, 2020
Fiat Lux
[/FONT][FONT=Arial, Helvetica, sans-serif]FEATURED TRADE:[/FONT][FONT=Arial, Helvetica, sans-serif](MY 20 RULES FOR TRADING IN 2021)[/FONT][FONT=Arial, Helvetica, sans-serif]
mti-pos-80.jpg
[/FONT]

My 20 Rules for Trading in 2021

Nothing like starting the new year with going back to basics and reviewing the rules that worked so well for us in 2020. Call this the refresher course for Trading 101.
I usually try to catch three or four trend changes a year, which might generate 100-200 trades, and often come in frenzied bursts.

Since I am one of the greatest tightwads that ever walked the planet, I only like to buy positions when we are at the height of despair and despondency, and traders are raining off the Golden Gate Bridge like a winter downpour.

Similarly, I only like to sell when the markets are tripping on steroids and ecstasy and are convinced that they can live forever.


bridge.png

Some 99% of the time, the markets are in the middle, and there is nothing to do but deep research and looking for the next trade. That is the purpose of this letter.

Over the five decades that I have been trading, I have learned a number of trends and true rules which have saved my bacon countless times. I will share them with you today.

1) Don’t over trade. This is the number one reason why individual investors lose money. Look at your trades of the past year and apply the 90/10 rule. Dump the least profitable 90% and watch your performance skyrocket. Then aim for that 10%. Overtrading is a great early retirement plan for your broker, not you.

2) Always use stops. Risk control is the measure of the good hedge fund trader. If you lose all your capital on the lemons, you can’t play when the great trades set up. Consider cash as having an option value.

3) Don’t forget to sell. Date, don’t marry your positions. Remember, hogs get fed and pigs get slaughtered. My late mentor, Barton Biggs, told me to always leave the last 10% of a move for the next guy.

4) You don’t have to be a genius to play this game. If that was required, Wall Street would have run out of players a long time ago.

If you employ risk control and stops, then you can be wrong 40% of the time, and still make a living. That’s a little better than a coin toss. If you are wrong only 30% of the time, you can make millions.

If you are wrong a scant 20% of the time, you are heading a trading desk at Goldman Sachs. If you are wrong a scant 10% of the time, you are running a $20 billion hedge fund that the public only hears about when you pay $100 million for a pickled shark at a modern art auction.

If someone says they are never wrong, as is often claimed on the Internet, run a mile, because it is impossible. By the way, I was wrong 15% of the time in 2013. That’s what you’re paying for.

5) This is hard work. Trading attracts a lot of wide-eyed, naïve, but lazy people because it appears so easy from the outside. You buy a stock, watch it go up, and make money. How hard is that? The reality is that successful investing requires twice as much work as a normal job. The more research you put into a trade, the more comfortable you will become, and the more profitable it will be. That’s what this letter is for.

6) Don’t chase the market. If you do, it will turn back and bite you. Wait for it to come to you. If you miss the train, there will be another one along in minutes, hours, days, weeks, or months. Patience is a virtue.

7) Limit Your Losses. When I put on a position, I calculate how much I am willing to lose to keep it. I then put a stop just below there. If I get triggered, I just walk away. Emotion never enters the equation. Only enter a trade when the risk/ reward is in your favor. You can start at 3:1. That means only risk a dollar to potentially make three.

8) Don’t confuse a bull market with brilliance. I am not smart, just old as dirt.

9) Tape this quote from the great economist and early hedge fund trader of the 1930s, John Maynard Keynes, to your computer monitor: "Markets can remain illogical longer than you can remain solvent." Hang around long enough, and you will see this proven time and again (ten-year Treasuries at 0.32%?!).

10) Don’t believe the media. I know, I used to be one of them. There is a reason why they are talking heads and not billionaire traders. Look for the hard data, the numbers, and you’ll see that often the talking heads, the paid industry apologists, and politicians don’t know what they are talking about (the Gulf oil spill will create a dead zone for decades?).

Average out all the public commentary, and half are bullish and half bearish at any given time. The problem is that they never tell you which one is right (that is my job). When they all go one way, the markets usually go the opposite direction.


Dice.png


11) When you are running a long/short portfolio, 80% of your time is spent managing the shorts. If you don’t want to do the work, then cash beats a short any day of the week.

12) Sometimes the conventional wisdom is right.

13) Invest like a fundamentalist, execute like a technical analyst. This is what all the pros do.

14) Use technical analysis only, and you will buy every rally, sell every dip, and end up broke. That said, learn what an “outside reversal” is, and who the hell is that Italian guy, Leonardo Fibonacci.

15) The simpler a market approach, the better it works. Everyone talks about “buy low and sell high”, but few actually do it. All black boxes eventually blow up, if they were ever there in the first place.

16) Markets are made up of people. Understand and anticipate how they think, and you will know what the markets are going to do.

17) Understand what information is in the market and what isn’t and you will make more money.

18) Do the hard trade, the one that everyone tells you that you are “Mad” to do. If you add a position and then throw up on your shoes afterwards, then you know you’ve done the right thing. This is why people started calling me “Mad” 40 years ago. (What? Tech stocks were a huge buy the first week of January?).

19) If you are trying to get out of a hole, the first thing to do is quit digging and throw away the shovel. Sell everything. A blank position sheet can be invigorating ad illuminating.

20) Making money in the market is an unnatural act, and fights against the tide of evolution.

We humans are predators and hunters evolved to track game on the horizon of an African savanna. Modern humans are maybe 5 million years old, but civilization has been around for only 10,000 years.

Our brains have not had time to make the adjustment. In the market, this means that if a stock has gone up, you believe it will continue to do so.

This is why market tops and bottoms see volume spikes. To make money, you have to go against these innate instincts.

Some people are born with this ability, while others can only learn it through decades of training. I am in the latter group.



[FONT=Arial, Helvetica, sans-serif][/FONT]
[FONT=Arial, Helvetica, sans-serif]
Hunter.jpg
[/FONT]​
[FONT=Arial, Helvetica, sans-serif][/FONT][h=2]Great Hunter, Lousy Trader[/h][FONT=Arial, Helvetica, sans-serif][/FONT][FONT=Arial, Helvetica, sans-serif] [/FONT]
[FONT=Arial, Helvetica, sans-serif][/FONT]
[FONT=Arial, Helvetica, sans-serif]
john-snow-e1514508880916.jpg
[/FONT]


Quote of the Day"Bonds are priced artificially because you've got some guy buying tens of billions of dollars worth a month. That will change at some point, and when it does, people are going to lose a lot of money," said Oracle of Omaha, Warren Buffett.

Hot-Air-Balloon-e1416857733759.jpg


 

New member
Joined
Oct 9, 2004
Messages
2,770
Tokens
Bozzie:

Thanks again for sharing these articles. Have had to deal with some terrible health issues for my family so I been distracted to say the least. Sitting in a mostly cash position and looking to start putting some money back to work after the first of the year. Like seeing others opinions and ideas and you seem to put time and effort into your ideas.

GL on future investments. Will be glad to put 2020 behind and hopefully return to a bit more normal world in 2021.

Once again thanks for the articles.

Northern Star
 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
Hey Northern Star good to see you back.
I've been wondering where you've been actually, Smartmoney too...How are you feeling about battery /solar ? I played Vale SA for a bit, I know you're Information in the industry is deep..Seems like an $$$ inflow is inevitable "Opportunity Cost" has finally arrived for green energy it seems given the investment incentives on a state and federal level will increase. I don't know the segment at all from an investment standpoint but I've been reading on the fringe. Any input would be appreciated.





new-jt-banner-newsletter.png

Global Market Comments
December 11, 2020
Fiat Lux
FEATURED TRADE:(DECEMBER 9 BIWEEKLY STRATEGY WEBINAR Q&A),
(GLD), (FXA), (FXE), (FXC), (UUP), (FXB), (ABNB), (DASH), (TAN), (TLT), (TBT), (NZD), (DKNG), (SNOW), (AAPL), (CRSP), (RTX), (NOC)
mti-pos-77.jpg


December 9 Biweekly Strategy Webinar Q&A

Below please find subscribers’ Q&A for the December 9 Mad Hedge Fund Trader Global Strategy Webinar broadcast from Incline Village, NV with my guest and co-host Bill Davis.
Q: Is gold (GLD) about ready to turn around from here?
A: The gold bottom will be easy to call, and that’s when the Bitcoin top happens. In fact, we have a double top risk going on in Bitcoin right now, and we had a little bit of a rally in gold this week as a result. So, longer term you need actual inflation to show up to get gold any higher, and we may actually get that in a year or two.
Q: The US dollar (UUP) has been weak against most currencies including the Canadian dollar (FXC), but Canada has the same problems as the US, but worse regarding debt and so on. So why is the Canadian dollar going up against the US dollar?
A: Because it’s not the US dollar. Canada also has an additional problem in that they export 3.7 million barrels a day of oil to the US and the dollar value have been in freefall this year. Canada has the most expensive oil in the world. So, taking that out of the picture, the Canadian dollar still would be negative, and for that reason I've been recommending the Australian dollar (FXA) as my first foreign currency pick, looking for 1:1 over the next three years. Of the batch, the Canadian dollar is probably going to be the weakest, Australian dollar the strongest, and the Euro (FXE) somewhere in the middle. I don’t want to touch the British pound (FXB) as long as this Brexit mess is going on.
Q: Would you buy the IPO’s Airbnb (ABNB) and Dash (DASH)?
A: No on Dash. The entries to new competitors are low. Airbnb on the other hand is now the largest hotel in the world, and it just depends on what price it comes out at. If it comes out at a stupid price, like 50% over the IPO, I wouldn’t bother; but if you can get close to the IPO price, I would probably buy it for the long term. I think you would have another double if we got close to the IPO price, so that is worth doing. They have been absolutely brilliant in their management and the way they handled the pandemic; they basically captured all the hotel business because if you rent an apartment all by yourself, the COVID risk is much lower than if you go into a Hilton or another hotel. They also made a big push on local travel which was successful. They gave up long-distance travel, and they’re now trying to get you to explore your own area; and that worked beyond all expectations. Even I have rented some Airbnb’s out in the local area like in Carmel, Monterey, Mendocino, and so on and I came back disease-free.
Q: If the United States Treasury Bond Fund (TLT) goes to a 1.00% yield, what would that translate to in the (TBT) (2x short treasury ETF)?
A: My guess is probably about $18, which has been upside resistance for a long time, but it depends on how long it takes to get there. You have about a 3% a year cost of carry on the TBT that you don’t have in Treasuries.
Q: Should we buy China stocks when the current administration is so negative on China?

A: Yes, that’s when you buy them—when the current administration is negative on China; because when you get an administration that’s less negative on China, the Chinese stocks will all rocket. There’s an easy 20-30% in most of the headline Chinese stocks from here sometime in 2021. And I'm looking to add more Chinese stocks. I currently have Alibaba (BABA), and that’s working well. I want to pick up some more.
Q: What about the New Zealand currency ETF (NZD)?
A: It pretty much moves in sync with the Australian dollar, but it’s usually a few cents cheaper and more volatile.
Q: Legalized sports betting seems to be on the upswing. Where do you see DraftKings (DKNG) going?
A: I think it goes up. I think there’s going to be a recovery in all kinds of entertainment type activities. Draft Kings got a huge market share from the pandemic which they will probably keep.
Q: Do we use spreads when playing (FXA)?
A: Yes, you can probably do something like a $70-$72 here one month out and make some decent money.
Q: How do you feel about Snowflake (SNOW)?
A: I wanted to get into this from day one, but it doubled on the IPO, and then it doubled again. It’s one of the only technology stocks Warren Buffet has bought in the last several years besides Apple (AAPL). So, it’s just too popular right now, it’s hotter than hot. They have a dominant market share in their big data platform, so it’s a great place to be but it’s really expensive now.
Q: Do your options trade alerts have any risk of assignment?
A: Yes, they do, but when you get an assignment it’s a gift, because they’re taking you out of your maximum profit point, weeks before the expiration. All you do is tell your broker to use your long position to cover your short position, and you will get the 100% profit right then and there. I say this because the brokers always tell you to do the wrong thing when you get an assignment, such as going into the market to close out each leg separately. That is a huge mistake, and only makes money for the brokers. For more details, log in here and search for “assignments”.
Q: Congratulations on your great performance; what could derail your bullish prediction?
A: Well, we’ve already had a pandemic so obviously that’s not it, and then you have to run by your usual reasons for an out-of-the-blue crash; let’s say Donald Trump doesn't leave the presidency. That would be worth a few thousand points of downside. So would a major war. We could have both; we could have a major war before a disrupted inauguration. The president has essentially unlimited ability to go to war at any time, so there aren’t too many negatives on the near-term horizon, which is why everyone is super bullish.
Q: What’s your opinion on the solar area, stocks like First Solar (FSLR) and the Invesco Solar ETF (TAN)?
A: I’m bullish. Even though they're over 300% since March, we’re about to enter the golden age of solar. Biden wants to install 500,000 solar panels next year and provide the subsidies to accomplish that. This all looks extremely positive for solar. In California, a lot of people will go solar, because getting an independent power supply protects you from the power shut-offs that happen every time the wind picks up, in which response to wildfire danger. We had ten days of statewide power blackouts this year.
Q: What are your thoughts on lithium?
A: I’m not a big believer in lithium because there is no short supply. The key to producing lithium is finding countries with no environmental controls whatsoever because it’s a very polluting and messy process to mine. Better to let other countries mine your lithium cheap, refine it, and then send it to you in finished form.
Q: Since you love CRISPR (CRSP) at $130, what about shorting naked puts? The premiums are really high.
A: I never advocate shorting naked puts. Occasionally, I will at extreme market bottoms like we had in March, but even then, I do it only on a 1 for 1 basis, meaning don’t use any leverage or margin. Never short any more puts than you’re willing to buy the stock lower down. People regularly see the easy money, sell short too many puts, and then get a market correction and a total wipeout of their capital. And they won't have to do that liquidation themselves; their broker will do it for them. They’ll do a forced liquidation of your account and then close it because they don't want to be left holding the bag on any excess losses. You won’t find out until afterwards. So, I would not recommend shorting naked puts for the normal investor. If you want to be clever, just buy an in-the-money call spread, something like a $110-$120 out a couple of months. That's probably a far better risk reward than shorting a naked put. By the way, I came close to wiping out Solomon Brothers 30 years ago because my hedge fund was short too many Nikkei Puts. In the end, I made a fortune, but only after a few sleepless nights (remember that Mark?).
Q: What do you think about defense stock right now?
A: I’m avoiding defense stock because I don’t see any big increases in defense spending in the future administration, and that would include Raytheon (RTX), Northrop Grumman (NOC), and some of the other big defense stocks.
SEE YOU ALL IN 2021!

Good Luck and Stay Healthy.

John Thomas
CEO & Publisher
The Diary of a Mad Hedge Fund Trader


john-bike.jpg


Quote of the Day

“Sometimes, when you jump off a bridge, you have to grow your wings on the way down,” said author Danielle Steele.

birds.png



 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
LISTEN TO TODAY'S PODCAST AVAILABLE AT 8AM ON:
Top News
shutterstock_686227327.jpg
Shutterstock​
The S&P 500 and Nasdaq fell Friday, weighed by the continued stalemate over a coronavirus stimulus deal, while the Dow Jones average eked out a gain but its performance was overstated by one stock, Disney, which added over 150 points to the average. New York's Governor Cuomo announced a halt of indoor dining at New York City restaurants after COVID-19 statistics surpassed safety benchmarks. Shares of companies hardest hit by the pandemic, including Carnival, United Airlines and Gap, were some of Friday's biggest losers. There was more progress on COVID vaccines during the week, but November's rally may have priced in all the good news for now. For the week, the S&P fell 1%, the Nasdaq lost 0.7% and the Dow slipped 0.6%.
Covid
The U.K. began administering the first COVID-19 vaccines to the public after becoming the first country in the world to approve a jab from Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX). The first recipient was grandmother Margaret Keenan, who received the shot at University Hospital Coventry, one of a network of hospital hubs where the initial phase of the U.K. program will be rolled out on what has been dubbed "V-Day." The initial 800K doses in the Britain are going to people over 80 who are either hospitalized or already have outpatient appointments scheduled, along with nursing home workers. In the U.S., a panel of outside advisers to the FDA also voted to endorse emergency use of Pfizer's vaccine and HHS chief Alex Azar said Americans could begin getting it as soon as Monday. 66 comments
Consumer
As companies keenly await COVID-19 vaccines that promise to return staff to the office, a new survey from the Pew Research Center suggests that won't be so easy. More than half of U.S. employees currently working from home say they'd like to keep their remote arrangements beyond the pandemic and one-third of those surveyed said they want the option to telework at least sometimes (only 11% said they rarely or never want to work from home). There's also a clear educational divide. 62% of workers with a bachelor's degree or more education say their work can be done from home, compared with only 23% of those without a four-year college degree. Will the data weigh on office real estate or boost WFH technology providers? 33 comments
Sponsored By T. Rowe Price
Retirement planning can be intimidating at any age. When retirement seems so far in the future, it’s hard to plan for it with so many competing priorities in the present. Still, it’s important to make steady progress toward saving, no matter what your age. Savings benchmarks based on age and salary can serve as a helpful way to track progress against saving for retirement.Click to learn more
Tech
Facebook (NASDAQ:FB) got nailed with two lawsuits on Wednesday, one from the Federal Trade Commission and another from a group of 46 U.S. states, which both accused the company of abusing its monopoly power in social networking. The FTC suit focused on Facebook's acquisition of Instagram in 2012 and WhatsApp two years later, describing the deals as a way to stifle competition, while state attorneys general said its actions were a "buy or bury" approach toward its rivals. Is a divestment in the cards? Facebook denied the anti-competive practices, calling it "revisionist history" of two major acquisitions the government had approved several years ago, but said it would review recent complaints and provide further updates shortly. 171 comments
Media
Walt Disney (NYSE:DIS) wrapped up its Investor Day with a $1/month price bump (to $7.99/month) for Disney Plus and projecting 230M-260M subscribers by 2024 across all its streaming platforms. CEO Bob Chapek also revealed that Disney Plus currently has more than 86M subscribers (up 18% in the last month), sending the stock soaring, even as most of its theme parks remain closed due to COVID-19. Ring the register... The Kardashians are coming to Disney in 2021 on the entertainment giant's Hulu and Star streaming subsidiaries, Christian Bale is joining the Marvel Cinematic Universe and 10 Star Wars series spinoff series were announced following the success of The Mandalorian.
Economy
Reports had surfaced last weekend, but Elon Musk confirmed his relocation to Texas, joining one-fifth of Americans who have done a "pandemic move." "First of all, Tesla (NASDAQ:TSLA) and SpaceX (SPACE) obviously have massive operations in California. In fact, it's worth noting that Tesla is the last car company still manufacturing cars in California. SpaceX is the last aerospace company still doing significant manufacturing in California. For myself, yes I have moved to Texas," he told the WSJ's CEO Council summit. "If a team has been winning for too long, they do tend to get a little complacent, a little entitled and then they don't win the championship anymore. California has been winning for a long time," he added, doubling down on his displeasure with the state's regulatory environment. Many companies and tech leaders have shared similar sentiment. Hewlett Packard Enterprise (NYSE:HPE) recently relocated its headquarters from San Jose, California, to Houston, Texas, while Palantir (NYSE:PLTR) moved its HQ to Denver from Palo Alto. 166 comments
Tech
Not only did Uber (NYSE:UBER) parks plans for its self-driving car this week, it agreed to sell its flying taxi unit to Joby Aviation, a Northern California startup that just got a boost from the U.S. military. The first-of-its-kind safety endorsement was issued by the Air Force to Joby's electric vertical takeoff and landing (eVTOL) aircraft, laying the groundwork for eventual civilian certification of the technology and even approval of autonomous flights crossing American cities. "This is an exciting announcement because it means you are literally seeing a new market emerge," said Will Roper, head of Air Force acquisitions. "Not just for military missions, but for all missions, including commercial ones. We are excited to see what's to come for Joby and other companies pushing the boundaries of electric vertical takeoff and landing or flying cars." 23 comments
IPOs
December is usually a quiet time for the IPO market, but this year there is a flurry of offerings as the pandemic upends the traditional calendar. Airbnb (NASDAQ:ABNB) hosts from around the world rang their doorbells on Thursday to celebrate the company's public debut, with shares of the home rental business more than doubling on their first day of trade. The stock opened at $146 apiece, which is more than double its elevated $68 IPO price. "I don't know what else to say, I'm very humbled by it," CEO Brian Chesky said in an interview, as investors jumped back into fast-growing tech stocks and express exuberance for new listings. Hot money? The listing comes 24 hours after DoorDash (NYSE:DASH) soared to a $60B valuation in its first day of trade, while videogame company Roblox (RBLX) and the parent of online retailer Wish, ContextLogic (WISH), are also set to debut this month. 154 comments
Global
"There is now a strong possibility that we will have a solution that is more like an Australian relationship with the EU," Boris Johnson said in his first remarks since a crunch meeting in Brussels, suggesting a no-deal Brexit may be in the cards. What does that look like? Canberra largely does business with the EU based on World Trade Organization rules, and has few other arrangements in place, such as cooperation on science and trade in wine. With negotiations between the U.K. and EU still hung up over fishing rights, a competitive playing field and enforcement, some "Plan B" details are surfacing in case an agreement doesn't materialize before a weekend deadline. Shortly before Johnson's announcement, the EU released its Brexit backup strategy, including a shortlist on ensuring basic reciprocal air and road connectivity, as well as the possibility of reciprocal fishing access. Slight caveat: Most of the contingency measures will need compliance from the U.K. side, and any plans from Britain will need the same. 8 comments

U.S. Indices
Dow -0.6% to 30,046. S&P 500 -1.% to 3,663. Nasdaq -0.7% to 12,378. Russell 2000 +1.% to 1,911. CBOE Volatility Index +12.1% to 23.31.

S&P 500 Sectors
Consumer Staples -0.3%. Utilities -0.4%. Financials -1.8%. Telecom +0.1%. Healthcare -0.8%. Industrials -0.5%. Information Technology -1.4%. Materials -1.2%. Energy +1.1%. Consumer Discretionary -1.2%.

World Indices
London -0.1% to 6,547. France -1.8% to 5,508. Germany -1.4% to 13,114. Japan -0.4% to 26,653. China -2.8% to 3,347. Hong Kong -1.2% to 26,506. India +2.3% to 46,099.

Commodities and Bonds
Crude Oil WTI +0.6% to $46.55/bbl. Gold +0.2% to $1,843.7/oz. Natural Gas +0.8% to 2.596. Ten-Year Treasury Yield +0.2% to 138.02.

Forex and Cryptos
EUR/USD -0.06%. USD/JPY -0.11%. GBP/USD -1.57%. Bitcoin -4.%. Litecoin -9.3%. Ethereum -6.4%. Ripple -9.1%.

Top Stock Gainers
HighPoint Resources (NYSE:HPR) +210%. Phoenix Tree Holdings (NYSE:DNK) +165%. Blink Charging (NASDAQ:BLNK) +134%. Arcimoto (NASDAQ:FUV) +125%. AYRO Inc (NASDAQ:AYRO) +103%.

Top Stock Losers
Brainstorm Cell Therapeutics (NASDAQ:BCLI) -63%. Rapt Therapeutics (NASDAQ:RAPT)-45%. Beyondspring (NASDAQ:BYSI) -40%. Oncternal Therapeutics (NASDAQ:ONCT) -39%. Ebang International Holdings (NASDAQ:EBON) -30%.

Where will the markets be headed next week? Current trends and ideas? Add your thoughts to the comments section.



 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
Yesterdays MH


new-jt-banner-newsletter.png

Global Market Comments
December 14, 2020
Fiat Lux

FEATURED TRADE:
(MARKET OUTLOOK FOR THE WEEK AHEAD, or THE GREAT ASSET SHORTAGE),
(INDU), (PFE), (MRNA), (PTON), (DOCU), (ETSY),
(CAT), (JPM), (BABA), (TSLA), (TLT), (ABNB), (DIS)

mti-pos-65.jpg



The Market Outlook for the Week Ahead, or The Great Asset Shortage

Markets are wonderful arbiters of the laws of supply and demand.
When there is a shortage of a particular security, Wall Street has a magical ability to manufacture more by running the printing presses to meet supply, or in the modern incarnation, open the spreadsheets.

Except for this time.

The amount of new cash created by global quantitative easing and the prolific saving habits of locked up Americans are creating more demand than even this efficient highly process can accommodate.

Which means that prices can only go up.

How long and how far is anyone’s guess. My target for the Dow Average is 120,000 in ten years, but even I don’t expect that to take place in a straight line. So, we are all sitting on our hands waiting for the next pullback to buy into, which may….or may not ever happen.

A lot of Dotcom Bubble memories are rising up from the dead. Analysts in 1999 made outlandish forecasts of stocks rising 50% in a year, which then took place in four days. That happened to Tesla (TSLA) last month and Airbnb (ABNB) last week.

In the meantime, the smartest traders, call them the oldest traders, are taking profits on the best years of their careers.


Of course, the short-term direction of the market will be determined by the January 5 Georgia Senate election, where the polls are in a dead heat. The last time this happened, during the presidential election, the Democrats won by a microscopic 15,000 vote margin.

If history repeats itself, the Biden administration will get an extra $6 trillion to play with to restore the shattered US economy. Think $2 trillion for infrastructure spending in all 50 states, $2 trillion for the rescue of bankrupt states and municipalities, $1 trillion for alternative energy and EV subsidies, and another $1 trillion in odds and ends. Needless to say, much of this will end up in the stock market.

I am getting a lot of questions these days regarding what will end this once-in-a-generation runaway bull market. The pandemic created this bull market by accelerating technology, business evolution, and corporate profitability by ten years. I bet a year ago, you weren’t spending your day on Zoom meetings, as I was.

The great irony is that the Pfizer (PFE) and Moderna (MRNA) vaccines may not only kill Covid-19, but the bull market as well. That’s because money will then come out of stocks and go back to the real economy.

That makes pandemic darlings like Peloton (PTON), DocuSign (DOCU), and Etsy (ETSY) especially risky. But then 6% growing GDPs were never what stock market crashes were made of, so any declines will be modest.

As for my own positions, I have a rare 100% long portfolio, mostly Tesla, but also the (TLT), (CAT), (JPM), and (BABA), 80% of which expires with the option expiration on Friday, December 18.

After that, I’ll take it easy with 10% short (TLT) and 10% long (TSLA) and wait for the market, or Georgians to tell me what to do.

A flood of money is to hit the stock market, says hedge fund legend Ray Dalio. The US is facing a perfect storm in favor of all risk assets. There is no reason why price earnings multiples for American stocks can’t reach 50X, double the current 25X. Buy what the central banks are buying. The funny thing is that I agree with Ray on everything. Buy risk on dips.

Stocks will keep soaring into 2021, says JP Morgan strategist Marko Kolanovik. The more risk the better. The Fed will keep interest rates low for at least another year, and ultra-low rates will force big institutions out of bonds and into stocks. Volatility (VIX) will decline. It all sounds like a great long stock/short bond trade to me. Hmmmmm.

Tesla completed a $5 Billion share issue, after a move to $650, up $142 from my November Mad Hedge BUY recommendation. The stock seems hell-bent on testing the Goldman Sachs $780 price recommendation before the December 18 S&P 500 entry. Elon Musk’s creation is now worth a staggering $608 billion. It’s the best recommendation in the 13-year history of the Mad Hedge Fund Trader.

San Francisco rents dive 35%, as tech workers flee to the suburbs. A lot of remote work is now permanent. Studio apartments are now a mere $2,100, and a one-bedroom can be had for $2,716. For a two-bedroom if you have to ask, you don’t need to know. Shocking!

Sales of million-dollar homes are soaring, as ultra-low interest rates persist and people spend much more time at home. So, bigger for your pod is better. Mortgages over $766,000 are up 57% YOY.

Jamie Diamond says he wouldn’t touch bonds with a ten-foot pole, and nor would I. A 91-basis point yield just doesn’t do it for the chairman of JP Morgan Chase (JPM), one of my recurring longs. Stocks are a much better choice, even if there is a bubble in progress. Keep selling every rally in fixed income, especially the (TLT).

Weekly Jobless Claims soar to 853,000, up a massive 153,000 from the previous week. To see this happen during the Christmas hiring season is heartbreaking. With 200,000 a day falling to Covid-19, I’m surprised it's not higher, which means it will be. This is what peaks look like. Washington has totally given up.

An $800 billion payday for the bay area. That is the amount of wealth created by just two companies, Tesla (TSLA) and Airbnb (ABNB), since March. And the great majority of shareholders live in the San Francisco Bay Area, including its venture capital and pension funds. No wonder home prices in the suburbs are up 20% YOY. The great irony is that (ABNB) received a massive government bailout only in March. I hope they repay the loans early.

Is Cuba the next big play? A Biden détente could lead to the emerging market investment opportunity of the decade with the $43 million Herzfeld Caribbean Basin Fund (CUBA). It just had its best month in 11 years (like many of us). With Fidel Castro long dead, what’s the point in continuing a 60-year-old cold war. A big market for American products and services beckons, not to mention the tourism and cruise opportunities. But can Biden afford to lose the Florida Cuban vote in the next election?

When we come out the other side of the pandemic, we will be perfectly poised to launch into my new American Golden Age, or the next Roaring Twenties. With interest rates still at zero, oil cheap, there will be no reason not to. The Dow Average will rise by 400% to 120,000 or more in the coming decade. The American coming out the other side of the pandemic will be far more efficient and profitable than the old. Dow 120,000 here we come!

My Global Trading Dispatch catapulted to another new all-time high. December is up 8.55%, taking my 2020 year-to-date up to a new high of 64.99%.

That brings my eleven-year total return to 420.90% or more than double the S&P 500 over the same period. My 11-year average annualized return now stands at a nosebleed new high of 38.26%. My trailing one-year return exploded to 66.30%, the highest in the 13-year history of the Mad Hedge Fund Trader.

The coming week will be a slow one on the data front. We also need to keep an eye on the number of US Coronavirus cases at 16 million and deaths 300,000, which you can find here.

When the market starts to focus on this, we may have a problem.

On Monday, December 14 at 12:00 PM EST, US Consumer Inflation Expectations for November are released.

On Tuesday, December 15 at 11:00 AM, the New York Empire State Manufacturing Index for December are published.
On Wednesday, December 16 at 8:00 AM, US Retail Sales for November are printed.
On Thursday, December 17 at 8:30 AM, the Weekly Jobless Claims are published. We also get November Housing Starts.
On Friday, December 18, at 2:00 PM, we learn the Baker-Hughes Rig Count.

As for me, I was stunned to learn that 84 million people are watching The Mandalorian, the latest Star Wars installment Disney (DIS) launched in its hugely successful streaming service a year ago.

It reminds me of when I first saw Star Wars in 1977. I was changing planes in Vancouver, Canada on the way to Tokyo and used a long layover to take a taxi to the nearest theater to catch a film I’d heard so much about.

I was amazed when I realized that the guy sitting in the next seat had memorized the entire script and was mouthing all the words. The only other time I have ever seen this happen was sitting on the benches at Shakespeare’s Globe Theater in London. At least then, they were reciting Romeo and Juliet.

Stay healthy.

John Thomas
CEO & Publisher
The Diary of a Mad Hedge Fund Trader

1yr-dec14.png

11yr-dec14.png

spy-dec14.png

tsla-dec14.png

baba-dec14.png

tlt-dec14.png

jpm-dec14.png


Quote of the Day

“It’s a funny thing about life. If you refuse to accept anything but the best, you very often get it,” said British Novelist, Somerset Maugham.

Number-1.png







 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens


new-jt-banner-newsletter.png

Global Market Comments
December 15, 2020
Fiat Lux

FEATURED TRADE:

(A NOTE ON OPTIONS CALLED AWAY),
(MSFT), (TLT), (BA), (GOOGL), (SPY)

mti-pos-72.jpg



A Note on Assigned Options, or Options Called Away

I know all of this may sound confusing at first. But once you get the hang of it, this is the greatest way to make money since sliced bread.
I still have a record eight positions left in my model trading portfolio, and they are all deep in-the-money. That opens up a set of risks unique to these positions. I call it the “Screw up risk.”

Here they are:

the Tesla (TSLA) December 2020 $392-$420 in-the-money vertical Bull Call spread

the Tesla (TSLA) December 2020 $400-$430 in-the-money vertical Bull Call spread

the Tesla (TSLA) December 2020 $450-$480 in-the-money vertical Bull Call spread

the iShares Barclays 20+ Year Treasury Bond Fund (TLT) December2020 $148-$151 in-the-money vertical bull call

the iShares Barclays 20+ Year Treasury Bond Fund (TLT) December2020 $164-$167 in-the-money vertical Bear Put spread

the JP Morgan (JPM) December 2020 $100-$105 in-the-money vertical Bull Call spread

the Caterpillar (CAT) December 2020 $145-$150 in-the-money vertical Bull Call spread

the Alibaba (BABA) December 2020 $220-$240 in-the-money vertical Bull Call spread


As long as the markets maintain current levels through Friday, ALL of these positions will expire at their maximum profit values.

With the December 18 options expirations only four trading days away, there is a heightened probability that your short position in the December options gets called away.

If it happens, there is only one thing to do: fall down on your knees and thank your lucky stars. You have just made the maximum possible profit for your position instantly.
Most of you have short option positions, although you may not realize it. For when you buy an in-the-money vertical option spread, it contains two elements: a long option and a short option. The short options can get “assigned,” or “called away” at any time, as it is owned by a third party, the one you initially sold the put option to when you initiated the position.

You have to be careful here because the inexperienced can blow their newfound windfall if they take the wrong action, so here’s how to handle it correctly.

Let’s say you get an email from your broker telling you that your call options have been assigned away. I’ll use the example of the Caterpillar call spread.

For what the broker had done in effect is allow you to get out of your call spread position at the maximum profit point four days before the December 18 expiration date. In other words, what you bought for $4.40 in November is now $5.00, giving you a near-instant profit of 13.63%!

In the case of the Caterpillar (CAT) December 2020 $145-$150 in-the-money vertical bull call spread, all you have to do is call your broker and instruct them to “exercise your long position in your (CAT) December 18 $145 calls to close out your short position in the December 18 $150 calls.”

This is a perfectly hedged position, with both options having the same name and the same expiration date, so there is no risk. The name, number of shares, and number of contracts are all identical, so you have no exposure at all.

Calls are a right to buy shares at a fixed price before a fixed date, and one options contract is exercisable into 100 shares.

To say it another way, you bought the (CAT) at $145 and sold it at $150, paid $2.40 for the right to do so, so your profit is 60 cents, or ($0.60 X 100 shares X 23 contracts) = $1,380. Not bad for an 22-day limited risk play.

Sounds like a good trade to me.

Weird stuff like this happens in the run-up to options expirations like we have coming.

A call owner may need to buy a long (CAT) position after the close, and exercising his long December $150 call is the only way to execute it.

Adequate shares may not be available in the market, or maybe a limit order didn’t get done by the market close.

There are thousands of algorithms out there which may arrive at some twisted logic that the puts need to be exercised.

Many require a rebalancing of hedges at the close every day which can be achieved through option exercises.

And yes, options even get exercised by accident. There are still a few humans left in this market to blow it by writing shoddy algorithms.

And here’s another possible outcome in this process.

Your broker will call you to notify you of an option called away, and then give you the wrong advice on what to do about it.

This generates tons of commissions for the broker but is a terrible thing for the trader to do from a risk point of view, such as generating a loss by the time everything is closed and netted out.

There may not even be an evil motive behind the bad advice. Brokers are not investing a lot in training staff these days. In fact, I think I’m the last one they really did train.

Avarice could have been an explanation here but I think stupidity and poor training and low wages are much more likely.

Brokers have so many ways to steal money legally that they don’t need to resort to the illegal kind.

This exercise process is now fully automated at most brokers but it never hurts to follow up with a phone call if you get an exercise notice. Mistakes do happen.

Some may also send you a link to a video of what to do about all this.

If any of you are the slightest bit worried or confused, by all of this, come out of your position RIGHT NOW at a small profit! You should never be worried or confused about any position tying up YOUR money.

Professionals do these things all day long and exercises become second nature, just another cost of doing business.

If you do this long enough, eventually you get hit. I bet you don’t.


Call-Options.png
[h=2]Calling All Options![/h]​


Quote of the Day

“Stock prices have reached what looks like a permanently high plateau,” said economist Irving Fisher….just before the 1929 stock market crash.
quote-dec15.png








 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
Up 60% today and sold....It'll do this again a few times, buy in the teens and wait...I love waiting.

https://www.cnbc.com/quotes/?symbol=MNKKQ
MNKKQ
Up 53% today..Watch for a drop and buy again..I missed this bump up but I'm going to watch it closely over the next few weeks.
Edit : dropped 20% in seconds..up 33% today now...This is a flippers stock now..being day traded heavily great volume for a company in bankruptcy with litigation pending..crazy
 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
And back up to 12% and sold again, all of it... only Placed half of the money I started playing with in this swing today..This shit scares me.
 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
And heading back down...Lost 5% again.

Then back up 15% in seconds back to 50% up today..I'm done for the day I think.
Fun to watch..could get stuck bad here... Shark computer algo warning.
 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
AVDL...great call..Very bullish on this.
you'll need to sign up..hold this and win IMO.

https://wsw.com/webcast/evercore11/...tps://wsw.com/webcast/evercore11/avdl/2343627


AVDL
Nice move over the past few days 8 dollars looks very doable today...Up from 6.60 on Dec 7th
Buyout within a year and it could be juicy depending on results


Avadel files US application for its lead drug


Dec. 16, 2020 8:44 AM ETAvadel Pharmaceuticals plc (AVDL)By: Vandana Singh, SA News Editor

  • Avadel Pharmaceuticals (NASDAQ:AVDL) rises 6% in premarket after submitting its marketing application to the FDA seeking approval for its lead candidate FT218, once-nightly formulation of sodium oxybate using Micropump technology for extended-release oral suspension, for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy.
  • In April this year, the company announced positive results from a Phase 3 trial. The study met all three co-primary endpoints at all three doses tested demonstrating statistically significant improvements compared to placebo.








 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
[h=1]This, I like..big vote of confidence here being included in a very well preforming index fund. Analyst coverage increases as well 5 strong buy recommends suddenly or I didn't notice till now..I'm not so in to analyst coverage but I'll take it here..This ones been a though hold at times. Target $ 18.00... Buy on the dips


Larimar, Avadel, Applied Therapeutics will added to Nasdaq Biotechnology Index[/h]Dec. 15, 2020 11:30 AM ETLarimar Therapeutics, Inc. (LRMR)By: Akanksha Bakshi, SA News Editor

  • Larimar Therapeutics (LRMR -3.4%), Avadel Pharmaceuticals (AVDL+1.7%) and Applied Therapeutics (APLT +2.5%) have been selected to be included in the NASDAQ Biotechnology Index.
  • The addition to the index will become effective prior to market open on Monday, December 21.
  • In comparison to the gain in the iShares NASDAQ Biotechnology Index Fund (IBB -0.8%) past 1-year performance, which tracks the index, LRMR has garnered higher returns, while AVDL and APLT have under performed during the same period.




 

Member
Joined
Dec 13, 2007
Messages
13,087
Tokens
Interesting..Surprised he didn't include BABA given the recent pull back..Topping out isn't a problem for BABA right now, Plenty of room to make a run at 300+..Done for the day.




new-jt-banner-newsletter.png

Global Market Comments
December 16, 2020
Fiat Lux
FEATURED TRADE:(WHAT TO BUY AT MARKET TOPS?),
(CAT), ($COPPER), (FCX), (BHP), (RIO),

(EUROPEAN STYLE HOMELAND SECURITY),
(TESTIMONIAL)
mti-pos-76.jpg


What to Buy at Market Tops?

I will start today’s letter by listing six more data points showing how overbought stocks have become.
1) While the number of outstanding shares in the US has remained unchanged since 2006, thanks to M&A, buybacks, bankruptcies, and privatizations, the average weighted share price has more than doubled from $50.15 to $137.00.

2) The Volatility Index (VIX) has just collapsed from a high of $41 in November to $20 today.

3) The Mad Hedge Market Timing Index has just soared from a record low of 2 eight months ago to 76 today, deep into “SELL” territory.

4) 2000 forward stock earnings growth has collapsed from 26% a year ago, to 0% in a few months.

5) Almost every investor now bullish once more, now that their stocks are going up.

6) The stock market has had its best month since 1987. Grizzled, long in the tooth readers can’t be more cautious right now.

This all leads to the urgent question of the day, WHICH stocks do you buy as we approach market tops? The answer is very simple. You buy cheap ones. And what are the cheapest stocks out there?

Commodity stocks.

My friend, Jim Umpleby, said that we are just entering a ten-year super cycle in commodities.

Jim should know. He is the CEO of Caterpillar (CAT), a company I have been following for 45 years. I even have one of their cool worn yellow baseball caps from years past.

Thanks to the 2017 tax bill, companies can now buy Caterpillar’s bulldozers, backhoes, and heavy trucks, and expense 100% of the investment in the first year. (Last year, I bought a new $162,500 Tesla Model X using the same break). That makes a purchase of (CAT)’s products one of the best tax breaks ever.

Needless to say, this has created a stampede to buy the companies heavy machinery because they fear this tax windfall will be reversed by the next administration. This is equipment with a 30-year life or longer.

Industrial commodities are in fact the perfect sector to buy right now. Take a look at the long-term chart for copper prices, which are a great bellwether for the entire industry. They are imminently poised to make a long-term upside breakout.

Copper last peaked at the beginning of 2011, when the Chinese infrastructure build-out suddenly outdrew to a juddering halt. Prices cratered from $4.60 a pound to a lowly $1.90. Mines were sold off, mothballed, or permanently closed at a record rate.

Copper prices fell so low that the US Mint finally started making a profit on pennies they struck.

Then a funny thing happened.

Copper bottomed, assisted by the global synchronized economic recovery I have been writing about for years. Then at the beginning of this year, investors smelled a recovery in a severely oversold, bargain basement, lagging sector. Copper prices jumped from $2.60 to $3.6, up 42% since June.

The share prices of copper and other major commodity producers went ballistic. Freeport McMoRan (FCX), the world’s largest copper producer, (whose management is a long-time reader of this letter) has just seen its stock jump six-fold from a near $4.00 a share to $24.00. If this sounds rich, recall that the peak during the last cycle was at $51.

Other big commodity producers did as well. Australia’s BHP Billiton (BHP) leaped 41% in a month!

You may think that it’s too late to get into the commodities space, but you’d be wrong. Having covered the sector for nearly a half-century there is one thing you learn quickly. While you can shut down a mine in weeks, it can take years to bring them back on line.

As for developing a new mine from scratch, that can take a decade by the time you get the design, permits, infrastructure, equipment, and labor in place.

My Australian readers tell me that (BHP) is flying young skilled workers from Brisbane an incredible 2,000 miles to work in Northwest mines in a six week on, six week off work schedule and paying them $200,000 a year to do it. And they’re making a profit doing this!

The bottom line here is that a short squeeze has developed for industrial commodities which will last for years.

Oh, and that global economic recovery? It is on vacation until the pandemic ends. That could happen in a few months, and no more than a year.

At least you have something to buy now besides more technology stocks. As much as we here at the Mad Hedge Fund Trader all love them for the long term, they are extremely overbought for the short term. Up 50% in a month? I’ll pass.


copper-dec16.png

fcx-dec16.png

bhp-dec16.png

cat-dec16.png

oil-e1515537097906.jpg
[h=2]Commodities Are In Our Blood[/h]​



European Style Homeland Security

I have just seen the movie “Dunkirk” for the second time, a film that is close to me because I knew several of the participants. A boat that made the crossing memorialized with a bronze plaque moored in the canal in front of my West London mansion for several years.
I also recall a lunch I had with British comedian John Cleese many years ago (he is my height) soliciting an investment in my hedge fund. He kept his money, but I recall with great humor his version of homeland security.

The English are feeling the pinch in relation to recent geopolitical events, and have therefore raised their security level from "Miffed" to "Peeved."

Soon, though, security levels may be raised yet again to "Irritated" or even "A Bit Cross." The English have not been "A Bit Cross" since the blitz in 1940, when tea supplies nearly ran out.

Terrorists have been re-categorized from "Tiresome" to "A Bloody Nuisance." The last time the British issued a "Bloody Nuisance" warning level was in 1588, when threatened by the Spanish Armada.

The Scots have raised their threat level from "Pissed Off" to "Let's get the Bastards." They don't have any other levels. This is the reason they have been used on the front line of the British army for the last 300 years.

The French government announced yesterday that it has raised its terror alert level from "Run" to "Hide." The only two higher levels in France are "Collaborate" and "Surrender." The rise was precipitated by a recent fire that destroyed France's white flag factory, effectively paralyzing the country's military capability.

Italy has increased the alert level from "Shout Loudly and Excitedly" to "Elaborate Military Posturing." Two more levels remain: "Ineffective Combat Operations" and "Change Sides."

The Germans have increased their alert state from "Disdainful Arrogance" to "Dress in Uniform and Sing Marching Songs." They also have two higher levels: "Invade a Neighbor" and "Lose."

Belgians, on the other hand, are all on holiday as usual; the only threat they are worried about is NATO pulling out of Brussels.

The Spanish are all excited to see their new submarines ready to deploy. These beautifully designed subs have glass bottoms so the new Spanish navy can get a really good look at the old Spanish navy.

Australia, meanwhile, has raised its security level from "No worries" to "She'll be alright, Mate." Two more escalation levels remain: "Crikey! I think we'll need to cancel the barbie this weekend!" and "The barbie is canceled." So far no situation has ever warranted use of the final escalation level.

-- John Cleese - British writer, actor and tall person.

John-Cleese.png




Testimonial

Hey John and the MAD Team, here's an advance Happy New Year!
You really nailed and keep nailing great reversals and trends that are just beginning to deserve a watchful eye. I nailed it today, so far, just buying the JPY pairs, and shorting the big bond, this past couple of weeks.
I'm still a bit stuck on futures, but I realize the safety in your spreads is a lot smarter...Thx for all you know and for all you do.
Rod
Alberta, Canada

John-Thomas3-e1437059748891.jpg



Quote of the Day

“Fear of missing out is losing to fear of looking stupid,” said Roelof Botha, partner at venture capital firm Sequoia Capital.
window-blinds.png


 

Forum statistics

Threads
1,118,025
Messages
13,550,626
Members
100,559
Latest member
walterjohnson3202
The RX is the sports betting industry's leading information portal for bonuses, picks, and sportsbook reviews. Find the best deals offered by a sportsbook in your state and browse our free picks section.FacebookTwitterInstagramContact Usforum@therx.com